Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. Shareholder Equity 2010–2025
Eloxx Pharmaceuticals, Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Eloxx Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: -11.9M, a 51.07% decrease year-over-year.
- Eloxx Pharmaceuticals, Inc. shareholder equity for 2025 were -11.9M, a 51.07% decrease from 2024.
- Eloxx Pharmaceuticals, Inc. shareholder equity for 2024 were -24.3M, a 7.68% increase from 2023.
- Eloxx Pharmaceuticals, Inc. shareholder equity for 2023 were -22.6M, a 182.21% decrease from 2014.
- Eloxx Pharmaceuticals, Inc. shareholder equity for 2014 were 27.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eloxx Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-12 |
| 2024 | $-24 |
| 2023 | $-23 |
| 2014 | $27 |
| 2013 | $4 |
| 2012 | $3 |
Eloxx Pharmaceuticals, Inc. Shareholder Equity — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELOX's shareholder equity history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.